4.5 Article

Sleep duration, C-reactive protein and risk of incident coronary heart disease - results from the Framingham Offspring Study

期刊

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.numecd.2013.12.012

关键词

Sleep duration; C-reactive protein; Coronary heart disease; Framingham Offspring Study

向作者/读者索取更多资源

Background: Both sleep-duration and C-reactive protein (CRP) are useful predictors of coronary heart disease (CHD). The increased CRP level is associated with the unusual sleep-duration. However, it is unclear whether CRP impacts the CHD risk prediction of sleep-duration. Methods and results: A total of 3381 individuals from the Framingham Offspring Study, aged 30+, CHD-free, and without missing measurement of CRP and sleep-duration and being followed to the end of 2007 were included in this analysis. Hazards ratio (HR) from the Cox regression models was used to evaluate the strength of association between the sleep-duration, CRP levels, and risk of incident CHD. Compared to sleep-duration 7-8 h (n = 2512) after adjusting for age and gender, the HR (95% CL) of incident CHD were 1.42 (1.15, 1.76, p < 0.005) for sleep-duration <= 6 h (n = 588) and 1.23 (0.90, 1.70, p < 0.2) for sleep-duration >= 9 h (n = 281), respectively. A further adjustment for other covariates including CRP did not change the CHD risk association. When subjects were categorized into 9 groups by sleep-duration (<= 6, 7-8, and >= 9 h) and CRP levels (<1, 1-3, and >= 3 mg/L), and compared to those whose sleep-duration was 7-8 h and CRP levels were <1 mg/L, the HRs of CHD were similar for sleep-duration in <= 6 h or >= 9 h categories regardless of their CRP levels. The increased CRP levels, however, did show an increased risk for CHD when sleep-duration was 7-8 h Conclusion: The levels of CRP do not significantly attenuate the association between sleep duration and incident CHD. Crown Copyright (C) 2014 Published by Elsevier B. V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据